Published in Women's Health Weekly, November 2nd, 2000
A clinical trial with a vitamin A derivative, fenretinide, has provided firm evidence that it protects younger patients in early stages of the disease against the formation of a second breast cancer. The result now points the way to the drug being used as a preventive in healthy young women at high risk of developing cancer.
Dr. Alberto Costa from the European Institute of Oncology Breast Division in Milan, Italy, said that in a multi-center trial in Italy of nearly 3,000 women with stage I breast cancer, half were randomized after surgery to receive five...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly